In this activity, Bruno Medeiros, MD, and Farhad Ravandi-Kashini, MD, discuss recent advances in the treatment of acute myeloid leukemia (AML). They discuss how new approvals have changed the paradigm for how AML is treated. A central topic in this program is how a better understanding of the molecular genetics of AML has led to new treatments. Dr. Medeiros and Dr. Ravandi-Kashini discuss the pathology and genetics that support the use of new targeted therapies, and the implications of findings from recent clinical trials.
1.00 AMA PRA Category 1 Credit™.
1.00 ANCC Contact Hour
|Opens:||April 30, 2019|
|Expires:||April 29, 2020|
Other Healthcare Providers